title: [Study of 45 patients with hepatocellular carcinoma complicating occlusion of the main portal vein].
authors.forename: T
authors.initials: T
authors.lastname: Kanno
authors.forename: K
authors.initials: K
authors.lastname: Kim
authors.forename: N
authors.initials: N
authors.lastname: Kurioka
authors.forename: S
authors.initials: S
authors.lastname: Harihara
authors.forename: S
authors.initials: S
authors.lastname: Yamamoto
authors.forename: T
authors.initials: T
authors.lastname: Monna
authors.forename: H
authors.initials: H
authors.lastname: Nakatsuka
authors.forename: K
authors.initials: K
authors.lastname: Minakuchi
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000150:complications*; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications*; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D011169:Portal Vein; D013927:Thrombosis / Q000209:etiology / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D008937:Mitomycins; D016685:Mitomycin